Routine Health Data in Medical Research: A Guide to Quality and Validity

A new professional guideline has been released to address the complexities of using routine data in medical research. This initiative aims to balance the immense potential of large-scale data with the need for scientific rigor.

The Potential of Routine Data

Routine data, which includes information from electronic health records, registers, and billing data, offer significant opportunities for the medical community. These sources allow researchers to analyse large patient collectives under real-world care conditions.

According to Dr. Sabine Hoffmann, head of the statistical consulting laboratory at LMU Munich and first author of the guideline, these data “open up enormous possibilities to investigate medical questions more quickly and broadly.”

Did You Know? Routine data in medical research is typically drawn from three primary sources: electronic health records, registries, and billing data.

Navigating Methodological Challenges

Despite the advantages, the guideline warns that routine data are linked to substantial methodological hurdles. These include insufficient data quality and a lack of representativeness in the samples studied.

View this post on Instagram about Expert Insight, Samantha Carter

From Instagram — related to Expert Insight, Samantha Carter

Researchers must also contend with non-randomized treatment decisions and a lack of temporal alignment between measurements and interventions. Such factors, along with a multitude of possible analysis paths, can lead to biased results.

Expert Insight: Samantha Carter notes that the tension here lies between speed and validity. While routine data can accelerate discovery, the stakes are high; without the methodological safeguards outlined in this roadmap, the risk of misleading conclusions could undermine trust in real-world evidence.

The Role of Artificial Intelligence

The guideline provides a critical assessment of modern analysis techniques, specifically methods involving Artificial Intelligence. While these tools possess great potential, the researchers warn they can lead to misleading results if not used with methodological care.

A Roadmap for Better Research

To combat these risks, the work introduces a structured roadmap and specific recommendations. These strategies focus on ensuring data quality and the correct definition of time points during studies.

The guideline also emphasizes the necessity of transparent and reproducible reporting. By following these steps, researchers may be able to avoid misinterpretations and increase the overall reproducibility of their findings.

Implementing these standards is likely to strengthen long-term confidence in results derived from routine data. This shift could potentially lead to more reliable evidence-based medical conclusions in the future.

Frequently Asked Questions

What exactly is routine data in a medical context?

Routine data refers to information gathered from sources such as billing data, registers, and electronic health records, reflecting patient collectives under real-world care conditions.

What are the primary risks associated with using this data?

Key challenges include poor data quality, lack of representativeness, biased results, and issues with how measurements and interventions are timed.

Can Artificial Intelligence help analyse this data?

Yes, AI methods have significant potential, but the guideline notes that they can produce misleading results if they are not applied with strict methodological care.

How do you think the use of real-world billing and health records will change the way new medical treatments are validated?